Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Land & Improvements (2013 - 2026)

Precigen (PGEN) posted quarterly Land & Improvements of $2.4 million for Q1 2026, up 1374.39% year-over-year from $164000.0 in Q1 2025, and little changed quarter-over-quarter from $2.4 million in Q4 2025.

Analysis

Precigen (PGEN) Land & Improvements (2013 - 2026) Analysis & Trends

Precigen (PGEN) has reported Land & Improvements for 14 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Land & Improvements rose 1374.39% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (up 1374.39% YoY), while the FY2025 annual figure was $2.4 million, down 24.42% from the prior year.
  • Land & Improvements held at $2.4 million in Q1 2026 per PGEN's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Land & Improvements topped out at $5.2 million in Q1 2022 and bottomed at $164000.0 in Q2 2022.
  • Historically, Land & Improvements has averaged $1.8 million across 5 years, with a median of $164000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Land & Improvements sank 97.15% — and 2026, when it soared 1374.39%.
  • Precigen's Land & Improvements stood at $4.6 million in 2022, then slipped by 24.18% to $3.5 million in 2023, then decreased by 7.89% to $3.2 million in 2024, then slipped by 24.42% to $2.4 million in 2025, then grew by 0.42% to $2.4 million in 2026.
  • Business Quant data shows PGEN's Land & Improvements at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $164000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 2.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.47 Mn
Mar 31, 2026 2.42 Mn
Dec 31, 2025 2.41 Mn
Sep 30, 2025 2.90 Mn
Jun 30, 2025 2.28 Mn
Mar 31, 2025 3.21 Mn
Dec 31, 2024 3.19 Mn
Sep 30, 2024 3.19 Mn
Jun 30, 2024 3.21 Mn
Mar 31, 2024 3.48 Mn
Dec 31, 2023 3.46 Mn
Sep 30, 2023 3.68 Mn
Jun 30, 2023 4.64 Mn
Mar 31, 2023 4.61 Mn
Dec 31, 2022 4.56 Mn
Sep 30, 2022 4.52 Mn
Jun 30, 2022 4.54 Mn
Mar 31, 2022 11.12 Mn
Dec 31, 2021 4.82 Mn
Sep 30, 2021 9.84 Mn